Adverse events176

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 176

Type	Event	Organ system	Group	Affected	At risk	Events
other	Cough	Respiratory, thoracic and mediastinal disorders	Double-blind Molgramostim Once Daily	15	46	22
other	Cough	Respiratory, thoracic and mediastinal disorders	Double-blind Molgramostim Intermittent	12	45	18
other	Cough	Respiratory, thoracic and mediastinal disorders	Double-blind Placebo	11	47	12
other	Cough	Respiratory, thoracic and mediastinal disorders	Open-label Molgramostim Intermittent	11	130	14
other	Nasopharyngitis	Infections and infestations	Double-blind Molgramostim Once Daily	7	46	10
other	Nasopharyngitis	Infections and infestations	Double-blind Molgramostim Intermittent	10	45	12
other	Nasopharyngitis	Infections and infestations	Double-blind Placebo	6	47	6
other	Nasopharyngitis	Infections and infestations	Open-label Molgramostim Intermittent	24	130	33
other	Headache	Nervous system disorders	Double-blind Molgramostim Once Daily	6	46	9
other	Headache	Nervous system disorders	Double-blind Molgramostim Intermittent	7	45	9
other	Headache	Nervous system disorders	Double-blind Placebo	7	47	16
other	Headache	Nervous system disorders	Open-label Molgramostim Intermittent	3	130	6
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Double-blind Molgramostim Once Daily	5	46	8
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Double-blind Molgramostim Intermittent	7	45	7
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Double-blind Placebo	4	47	5
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Open-label Molgramostim Intermittent	4	130	8
other	Alveolar proteinosis	Respiratory, thoracic and mediastinal disorders	Double-blind Molgramostim Once Daily	3	46	4
other	Alveolar proteinosis	Respiratory, thoracic and mediastinal disorders	Double-blind Molgramostim Intermittent	5	45	5
other	Alveolar proteinosis	Respiratory, thoracic and mediastinal disorders	Double-blind Placebo	8	47	18
other	Alveolar proteinosis	Respiratory, thoracic and mediastinal disorders	Open-label Molgramostim Intermittent	7	130	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02702180/events

API reference For AI assistants

Adverse events176

Sources 3

Read this list from software.